SCHEMBL26845908

SCHEMBL26845908

Cc1ccc2c(c1)CN(C(=O)CS(=O)(=O)c1nccs1)C2

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DPP8 Q6V1X1 3/20 0.40
▸ DPP9 Q86TI2 2/20 0.40
▸ DPP7 Q9UHL4 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ NAMPT P43490 6/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ DPP4 P27487 2/20 0.34
▸ KCNA1 Q09470 1/20 0.34
▸ KCNAB1 Q14722 1/20 0.34
▸ FAP Q12884 1/20 0.34
▸ LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987551 0.87 MAOB (0.39) NAMPTSMN1; SMN2HSP90AA1LMNA
SCHEMBL24814391 0.87 RYR2 (0.43) ALDH1A1NAMPTSMN1; SMN2HSP90AA1TP53
SCHEMBL24817122 0.86 NAMPT (0.44) DPP8DPP9DPP7NAMPTDPP4
SCHEMBL24817127 0.86 MAOB (0.40) ALDH1A1HSD17B10NAMPTSMN1; SMN2MEN1
SCHEMBL24815669 0.86 SMN1; SMN2 (0.42) ALDH1A1NAMPTSMN1; SMN2POLBLMNA
SCHEMBL29986905 0.86 SMN1; SMN2 (0.42) ALDH1A1NAMPTSMN1; SMN2POLBLMNA
SCHEMBL29987611 0.84 NAMPT (0.42) ALDH1A1NAMPTSMN1; SMN2POLBTP53
SCHEMBL24815798 0.84 NAMPT (0.42) ALDH1A1NAMPTSMN1; SMN2POLBTP53
SCHEMBL24815670 0.83 NLRP3 (0.35) ALDH1A1HSD17B10SMN1; SMN2MEN1KMT2A
SCHEMBL24814740 0.83 NLRP3 (0.35) DPP8DPP9NAMPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH DPP8 4457/4885DPP9 4490/4885DPP7 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback